Abstract: The invention relates to the use of oxaloacetate in the treatment of ischaemia. The invention provides quantities that are therapeutically effective for the treatment of disorders associated with high levels of glutamate in brain tissue, such as, for example, cerebral ischaemia. In addition, the compositions of the invention are suitable for bolus-type delivery.
May 13, 2011
May 23, 2013
UNIVERSIDADE DE SANTIAGO DE COMPOSTELA, HOSPITALARIO UNIVERSITARIO DE SANTIAGO (IDICHUS), SERVIZO GALEGO DE SAUDE (SERGAS)
José Castillo Sánchez, Tomá Sobrino Moreiras, Pedro Ramos Cabrer, Francisco Campos Perez, Jesús Agulla Freire, Bárbara Argibay González